Breakthrough genomic test identifies virtually any infection in one go
Researchers at University of California San Francisco (UCSF) have developed a single genomic test that can quickly detect virtually any kind of pathogen in a patient. This allows for much quicker diagnoses, enables targeted treatment to begin sooner, and could lower healthcare costs.
Study finds novel approach to treat neurological diseases
San Francisco: The matter of what causes complicated neurological disorders like Alzheimer's or multiple sclerosis continues to perplex scientists and
Stem-cell implants restore vision in patients with corneal stem cell deficiency
Researchers successfully tested the safety and preliminary efficacy of stem-cell-derived corneal implants, showing promise for restoring vision in patients with severe corneal damage.
New study links circadian gene variants to winter depression
Variants of the PER3 gene disrupt adrenal adaptation to winter light, leading to serotonin disruption and depression-like behaviors in humanized mice models.
Early radiosurgery for small cranial nerve tumors can prevent future complications
Patients with a small cranial nerve tumor that can cause hearing loss, vertigo, imbalance and ringing in the ears have typically been watched rather than proactively treated, as the risks of early intervention were thought to outweigh the benefits.
Western diet accelerates endometriosis growth and disrupts gut health
This study found that a Western diet doubles the growth of endometriotic lesions in mice and depletes the gut microbiome's beneficial bacterium, Akkermansia muciniphila, which may exacerbate endometriosis symptoms.
Georgia Tech researchers create lab-grown models of human immune systems
To better understand why some cancer patients struggle to fight off infections, Georgia Tech researchers have created tiny lab-grown models of human immune systems.
Early genomic profiling improves cancer treatment outcomes
New real-world data from Providence, Illumina, and Microsoft Research reveals that Comprehensive Genomic Profiling (CGP), when done early in a cancer patient's diagnosis, leads to better personalized treatment and patient outcomes.
New treatment combination improves outcomes for small cell bladder and prostate cancer patients
A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell/neuroendocrine prostate cancer.
Vitamin D supplementation may decrease blood pressure in obese older adults
Vitamin D supplements may lower blood pressure in older people with obesity and taking more than the Institutes of Medicine's (IOM) recommended daily dose does not provide additional health benefits, according to new research published in the Journal of the Endocrine Society.
Breakthrough method sheds light on how immune receptors detect infections
Researchers from the University of Bonn are using an innovative method to watch immune receptors go about their business.
New blood test detects early lung damage in cancer patients on targeted therapy
New study introduces a simple blood test to detect early lung damage in cancer patients receiving novel therapy with antibody-drug conjugates (ADCs), which can sometimes cause serious, even fatal, lung disease (ILD).
New study highlights the importance of BMI in disease pathogenesis
New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing BMI alone could lower the risk of several diseases.
Breakthrough discovery in treatment for deadly motor neurone disease
Scientists are working on a way to restore the production of a protein that is essential for communication in the brain and spinal cord, in a bid to slow down the progression of the deadly disease
Key reason why some cancers do not respond to immunotherapy identified
Research reveals SLC13A3's role in tumor cell survival and immune therapy resistance, highlighting its potential as a target for improved cancer treatments.
Revolutionary treatment for motor neurone disease on the horizon
There is currently no cure for the condition, which affects 5,000 people in the UK
Doctors reveal seven ways Gen Z can help reduce risk of early on-set cancer
It doesn't matter how old you are, cancer can affect you at any time. And now health experts have revealed the key steps young people can take to help prevent early onset cancer
Combination approach shows promise for treating rare, aggressive cancers
A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell/neuroendocrine prostate cancer.
Early treatment for nerve tumors prevents serious problems, study finds
Small cranial nerve tumors that can cause hearing loss, vertigo and ringing in the ears are often watched rather than treated, but a new study is set to change how the tumors, called vestibular schwannomas, are managed.
Glioblastoma: New treatment attacks brain tumors from multiple angles
Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells are too varied, and the microenvironment is too tumor-friendly. Researchers have now developed an immunotherapy that not only attacks the tumor -- it also turns its microenvironment against it.
New Antibody Treatment Boosts Immune Response Against Tumor: Study
Israeli researchers and their colleagues from the United States developed an antibody-based treatment that empowers the body's immune system to effectively attack cancer cells and prevent their spread, Israel's Weizmann Institute of Science said.
New antibody could be promising cancer treatment
Researchers have developed a new form of precision medicine, an antibody, with the potential to treat several types of cancer. Researchers have managed to combine three different functions in the antibody, which together strongly amplify the effect of T cells on the cancer tumor.
New strategy puts targets on brain cancer cells
Researchers have identified a possible way to make glioblastoma cells vulnerable to different types of immunotherapy.
One genomic test can diagnose nearly any infection
A genomic test developed by researchers to rapidly detect almost any kind of pathogen -- virus, bacteria, fungus or parasite -- has proved successful after a decade of use.
Researchers develop nanofiber patch for treatment of psoriasis
Researchers have developed a patch for easier and more effective treatment of psoriasis. The method may also be used in treatment of other inflammatory skin diseases.
Researchers develop new antibody with potential to treat several types of cancer
Researchers at Uppsala University and KTH Royal Institute of Technology have developed a new form of precision medicine, an antibody, with the potential to treat several types of cancer.
Scientists use microcellular drones to deliver lung cancer-killing drugs
In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable anti-cancer antisense oligonucleotides suppressed cancer growth.
Scientists use microcellular drones to deliver lung cancer-killing drugs
Extracellular vesicles (EVs) loaded with customizable anti-cancer antisense oligonucleotides suppressed cancer growth.
Targeted degradation of Pin1 shows promise for pancreatic cancer treatment
In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins.
Tumor suppressor forms gel-like assemblies to sacrifice cancer cells
Scientists uncovered a previously unrecognized tumor suppression mechanism through the study of condensates and ribosome formation.
Tumor suppressor forms gel-like assemblies to sacrifice cancer cells 
There are processes in the human body that can suppress the growth and proliferation of cancer cells. These mechanisms, including those involving the tumor suppressor protein p53, are widely studied due ...
VANCE trial marks milestone in t cell therapy for solid tumors
The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.
World's first stem cell treatment restores vision, offers new hope to the blind
A Lancet study highlights significant, lasting vision improvements in patients with damaged corneas using reprogrammed stem-cell transplants.
last updated on 14 Nov 03:58